BRCA2 and ovarian carcinoma: In conclusion, we have characterized the mutation spectrum of BRCA1/BRCA2 in a consecutive series of ovarian carcinomas, observing a frequency of 19.3% of deleterious variants, 13.3% germline, and 5.9% somatic.